At the same intervals, the tails were observed for spasticity
Metallothionein-3 (MT3), a brain-specific metalloprotein, serves as a primary antioxidant that rapidly responds to oxidative stress
Competing Interests P.K
Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage
Its remarkable stability derives primarily from four proline residues at positions 3, 4, 5, and 8, including a distinctive triple-proline (PPP) motif